Literature DB >> 34647435

Anxiety due to COVID-19 among healthcare providers during pandemic: A web-based cross-sectional survey in Iran.

Mahsa Kamali1, Mahmood Moosazadeh2,3, Marzieh Azizi4,5, Roya Ghasemian6, Maryam Hasannezad Reskati7, Forouzan Elyasi8,9.   

Abstract

AIM: The main purpose of this study was to assess the levels of anxiety, depression, and stress among healthcare providers in Iran.
METHODS: This descriptive cross-sectional survey was performed on healthcare providers selected through the convenience sampling method from April 6 to May 19, 2020, during the COVID-19 pandemic. To this end, a self-report web-based questionnaire made up of a sociodemographic characteristics information form, Depression, Anxiety, and Stress Scale (DASS), and Corona Disease Anxiety Scale (CDAS) was distributed. Descriptive statistics, chi-square test (χ2 ), and univariate and multivariate logistic regression models were accordingly practiced to analyze the data using the Statistical Package for Social Sciences (SPSS) software.
RESULTS: Of 1343 healthcare providers, 45.8% and 73.0% had moderate physical and psychological anxiety symptoms, respectively. The logistic regression model similarly demonstrated that anxiety caused by COVID-19 was significantly correlated with the age ranges of 41-50 (P = .007) and 51-60 (P = .014) years as well as male participants (P < .001). In addition, the prevalence rates of depression and stress were, respectively, reported by 35.1% and 27.8%. There was correspondingly a significant relationship between depression and age as well as stress and gender.
CONCLUSIONS: It seems that healthcare managers need to focus more attention on psychological aspects in healthcare providers during this pandemic and plan to teach them about coping strategies.
© 2021 The Authors. Neuropsychopharmacology Reports published by John Wiley & Sons Australia, Ltd on behalf of the Japanese Society of Neuropsychopharmacology.

Entities:  

Keywords:  anxiety; coronavirus; depression; healthcare workers; infection; stress

Mesh:

Year:  2021        PMID: 34647435      PMCID: PMC8646633          DOI: 10.1002/npr2.12213

Source DB:  PubMed          Journal:  Neuropsychopharmacol Rep        ISSN: 2574-173X


INTRODUCTION

The coronavirus disease 2019 (COVID‐19), primarily detected in the city of Wuhan, China, has currently converted into an ongoing pandemic. As declared by the World Health Organization on May 14, 2020, a total number of 4 258 666 confirmed cases of COVID‐19 and 294 190 deaths had been reported all over the world. So far, no specific and proven medication has been introduced for treatment of this infection. Moreover, quarantine and rapid increase in being infected with coronavirus (CoV) had harmful psychological effects on people including depression, anxiety, stress, and panic disorder, , which may aggravate if no treatment is proposed. Also, lockdown, wearing mask, and social distancing had reverse effects on mental health. At the onset of the COVID‐19 pandemic, Wang et al had reported that CoV outbreak had led to severe psychological effects on 53.8% of people. Another study in Iran had further found that 47% of Iranian citizens had experienced mild‐to‐moderate distress caused by COVID‐19 with different predictors from other countries including China. Accordingly, healthcare providers (HCPs) can be more often susceptible to many physical and psychosocial problems due to fears of transmitting the infection to their families, wearing protective clothing, and withholding food and drink in infectious diseases wards. , , Thus, these individuals are at higher risk with respect to the nature of their professions. So that, mortality rates may not be different between HCPs and general population. These situations can also bring about psychological distress in HCPs including anxiety, depression, and poor sleep quality. Likewise, increased workload among HCPs can make them quit their jobs and pose threats to healthcare facilities in terms of shortage of personnel. In China, 23.02% and 27.39% of HCPs had, respectively, experienced anxiety and anxiety disorder during the COVID‐19 outbreak. As well, 23.6% of the HCPs had reported the highest rate of poor sleep quality. An Italian study had additionally revealed that 49.38% of the HCPs had manifested post‐traumatic stress disorder (PTSD) and 24.73% of the cases had been presented with severe depression. Moreover, 19.80% and 8.27% of these individuals had suffered from anxiety and insomnia. In other studies conducted in Iran, 39.6%‐65.6% of hospital staff had been subjected to moderate‐to‐severe anxiety and 42.3% of the cases had shown moderate‐to‐severe depression during the COVID‐19 outbreak. , Regarding the results of previous studies, the spread of the COVID‐19 pandemic, and the rising trend in the number of infected people and HCPs, the main purpose of the present study was to assess the levels of depression, anxiety, and stress caused by COVID‐19 among HCPs in Mazandaran Province, northern Iran.

METHODS

This descriptive cross‐sectional survey was conducted on HCPs selected through the convenience sampling method from April 6 to May 19, 2020, during the COVID‐19 pandemic in Mazandaran Province, northern Iran, with at least 60 cities, as one of the first hotspots with a high prevalence rate of CoV infection. Following the COVID‐19 outbreak, a self‐report web‐based questionnaire was distributed through the cyberspace including popular messaging apps, that is WhatsApp, Instagram, and Short Message Service (SMS). An online informed consent was also signed by the participants before their inclusion in the study. The HCPs were comprised of doctors, nurses, dentists, pharmacists, laboratory personnel, radiologists, midwives, medical residents, medical students, and all staff who had interacted directly or indirectly with COVID‐19 patients in inpatient and outpatient wards of hospitals, fever clinics, prehospital emergencies, and primary healthcare centers. The sample size was also determined by 1318 participants with respect to the results of the study by Zhu et al, assuming 95% confidence interval (CI) and 13% of completion defects. The inclusion criteria were all HCPs who had experienced interactions with COVID‐19 patients directly or indirectly, showing willingness to participate in the study. Incomplete questionnaires were additionally excluded. The given questionnaire consisted of three parts: the sociodemographic characteristics information form, Depression, Anxiety, and Stress Scale (DASS), and Corona Disease Anxiety Scale (CDAS). The sociodemographic data included gender, age, marital status, place of living, level of education, field of study, working position, years of experience, history of mental and physical problems, number of children, and working units (inpatient or outpatient). The DASS was also used to evaluate the levels of depression, anxiety, and stress during the last week. This four‐point Likert‐type scale was scored with no, low, moderate, and high options respectively from 0 to 3. In this scale, depression had been divided into normal (0‐9), mild (10‐13), moderate (14‐20), severe (21‐27), and very severe (28 and more). Anxiety could be correspondingly rated as normal (0‐7), mild (8‐9), moderate (10‐14), severe (15‐19), and very severe (20 and more). In addition, stress points were normal (0‐14), mild (15‐18), moderate (19‐25), severe (26‐33), and very severe (34 and above). The internal consistency reliability of the construct with Cronbach's alpha values had been further reported at the range of .83‐.86. In its Persian version, the reliability of this instrument had been assessed by Jafari et al and respectively reported by 0.86, 0.76, and 0.79 for the dimensions of depression, anxiety, stress. The validity of the given questionnaire had been also reported with Cronbach's alpha coefficient greater than .7. Also, it was validated in different cultures during COVID‐19 pandemic. , , , The CDAS had been designed and validated to measure anxiety caused by CoV infection in Iran. The final version of this tool contained 18 items and two components (psychological and physical symptoms) scored from never (0) to always (3), so that, the highest and the lowest scores obtained by the respondents in this questionnaire could be between 0 and 54. Psychological symptoms were also rated as no or mild (0‐5), moderate (6‐19), and severe (20‐27). As well, physical symptoms consisted of no or mild (0‐1), moderate (2‐9), and severe (10‐27). High scores on this questionnaire could indicate a higher level of anxiety. The reliability of this tool had been further measured using Cronbach's alpha method for the first factor (α = .879), the second factor (α = .861), and the whole questionnaire (α = .919). This research project was approved by the Ethics Committee of Mazandaran University of Medical Sciences (IR.MAZUMS.REC.1399.7333), Sari, Iran. At the end of the questionnaire, the scores were also given as feedback to the participants. They were additionally assured that these scores were being used merely for screening purposes, but not treatment. Moreover, the HCPs who got high scores could contact the phone number 4030 (designed for free consultations by the Ministry of Health and Medical Education). In addition, the link of the educational files included videos and pamphlets prepared according to the HCPs' knowledge to teach them how to cope with depression, anxiety, and stress during this condition. Descriptive analysis was conducted to define the sociodemographic characteristics of the HCPs. The prevalence rate of depression, anxiety, and stress caused by COVID‐19 was also reported, and chi‐square test (χ 2) was used to compare the differences between the groups. Univariate and multivariate logistic regression models were subsequently performed to explore potential predictors for anxiety during the COVID‐19 outbreak. Odds ratio (OR) and 95% CI were similarly obtained from the logistic regression models. All the data were analyzed using the Statistical Package for Social Sciences (SPSS) software (version 24.0). P‐values less than .05 were considered statistically significant.

RESULTS

Sociodemographic characteristics information

The sociodemographic characteristics of the HCPs are shown in Table 1. A total number of 1343 HCPs participated in this study. The statistical tests also revealed that most of the participants aged 20‐30 years (37.1%). They were female (75.0%), married (71.8%), and had children (55.6%). These individuals were also holding a Bachelor's degree (57.2%), and they were nurses (42.4%), with working experience of 5 years or lower (36.3%), and permanent employment status (37.0%). These HCPs were working in isolated wards (55.6%), for 6‐8 hours with COVID‐19 patients (32.5%), and had no physical illnesses (75.6%) along with any major psychiatric disorders based on their self‐report (90.2%).
TABLE 1

Participants' sociodemographic characteristics

Sociodemographic characteristicsFrequency (%), N = 1343
Age groups (y)
20‐30498 (37.1)
31‐40459 (34.2)
41‐50296 (22.0)
51‐6083 (6.2)
>617 (0.5)
Gender
Male336 (25.0)
Female1007 (75.0)
Marital status
Single347 (25.8)
Married964 (71.8)
Divorced or widowed32 (2.4)
Having children
Yes747 (55.6)
No596 (44.4)
Level of education
Undergraduate133 (9.9)
Bachelor's degree768 (57.2)
Master's and PhD degree172 (12.8)
General and special professional doctorate270 (20.1)
Occupation
Clinician322 (24.0)
Nurse570 (42.4)
Midwife279 (20.8)
Other172 (12.8)
Working experience
0‐5487 (36.3)
5‐10252 (18.8)
10‐15253 (18.8)
15‐20151 (11.2)
>20200 (14.9)
Employment status
Conscription217 (16.2)
Contractual234 (17.4)
Corporate114 (8.5)
Temporary‐to‐permanent117 (8.7)
Permanent497 (37.0)
Other164 (12.2)
Working in isolated wards
Yes747 (55.6)
No596 (44.4)
Working units
Hospitals4157 (54.5)
Outpatient clinics751 (9.8)
Laboratories210 (2.8)
Imaging centers99 (1.3)
Others2409 (31.6)
Working hours with COVID‐19 patients
0210 (15.6)
1‐2214 (15.9)
2‐4127 (9.5)
4‐6182 (13.6)
6‐8436 (32.5)
>8174 (13.0)
History of physical illnesses
Yes328 (24.4)
No1015 (75.6)
History of psychiatric disorders
Yes132 (9.8)
No1211 (90.2)
Participants' sociodemographic characteristics

Prevalence of anxiety based on CDAS

The CDAS results are presented in Tables 2 and 3. Accordingly, 45.8% and 73.0% of the HCPs respectively had moderate physical and psychological anxiety symptoms. The results also showed that anxiety caused by COVID‐19 was significantly correlated with gender, age, level of education, occupation, working experience, employment status, working hours with COVID‐19 patients, and history of physical illnesses (P < .05).
TABLE 2

Prevalence of anxiety based on CDAS and DASS

Questionnaire domains and severity
CDASSeverity of anxiety, N = 1343 (%)
Without or mildModerateSevere
Physical symptoms509 (37.9)615 (45.8)219 (16.3)
Psychological symptoms134 (10.0)980 (73.0)229 (17.1)
TABLE 3

CDAS in participants during COVID‐19 outbreak in Mazandaran Providence population stratified by sociodemographic variables (N = 1343)

VariablesPhysical symptoms of anxietyPsychological symptoms of anxietyTotal score of CDAS
Without to mild (%)Moderate to severe (%)Very severe (%) χ 2 P‐valueWithout to mild (%)Moderate to severe (%)Very severe (%) χ 2 P‐valueWithout anxiety (%)With anxiety (%) χ 2 P‐value
Gender
Male161 (12.0)140 (10.4)35 (2.6)23.062<.00161 (4.5)235 (17.5)40 (3.0)37.555<.001221 (16.5)115 (8.6)25.701<.001
Female348 (25.9)475 (35.4)184 (13.7)73 (5.4)745 (55.5)189 (14.1)502 (37.4)505 (37.6)
Age groups
20‐30191 (14.2)219 (16.3)88 (6.6)9.381.31139 (2.9)351 (26.1)108 (8.0)22.161.005246 (18.3)252 (18.8)16.104.003
31‐40166 (12.4)227 (16.9)66 (4.9)49 (3.6)336 (25.0)74 (5.5)244 (18.2)215 (16.0)
41‐50110 (8.2)131 (9.8)55 (4.1)33 (2.5)220 (16.4)43 (3.2)169 (12.6)127 (9.5)
51‐6039 (2.9)34 (2.5)10 (0.7)12 (0.9)67 (5.0)4 (0.3)59 (4.4)24 (1.8)
>603 (0.2)4 (0.3)0 (0.0)1 (0.1)6 (0.4)0 (0.0)5 (0.4)2 (0.1)
Marital status
Single142 (10.6)153 (11.4)52 (3.9)5.916.20634 (2.5)249 (18.5)64 (4.8)3.840.428186 (13.8)161 (12.2)0.407.816
Married350 (26.1)452 (33.7)162 (12.1)95 (7.1)706 (52.6)163 (12.1)518 (38.6)446 (33.2)
Divorced or widowed17 (1.3)10 (0.7)5 (0.4)5 (0.4)25 (1.9)2 (0.1)19 (1.4)13 (1.0)
Having children
Yes266 (19.8)353 (26.3)128 (9.5)3.826.14885 (6.3)545 (40.6)117 (8.7)5.216.074398 (29.6)349 (20.6)0.209.648
No243 (18.1)262 (19.5)91 (6.8)49 (3.6)435 (32.4)112 (8.3)325 (24.2)271 (20.2)
Level of education
Undergraduate61 (4.5)46 (3.4)26 (1.9)20.788.00225 (1.9)85 (6.3)23 (1.7)27.027<.00174 (5.5)59 (4.4)15.652.001
Bachelor's degree267 (19.9)357 (26.6)144 (10.7)59 (4.4)559 (41.6)150 (11.2)380 (28.3)388 (28.9)
Master's and PhD degree68 (5.1)84 (6.3)20 (1.5)23 (1.7)131 (9.8)18 (1.3)100 (7.4)72 (5.4)
General and special professional doctorate113 (8.4)128 (9.5)29 (2.2)27 (2.0)205 (15.3)38 (2.8)169 (12.6)101 (7.5)
Occupation
Clinician135 (10.1)146 (10.9)41 (3.1)16.063.01335 (2.6)238 (17.7)49 (3.6)12.389.054196 (14.6)126 (9.4)17.059.001
Nurse188 (14.0)275 (20.5)107 (8.0)40 (3.0)424 (31.6)106 (7.9)271 (20.2)299 (22.3)
Midwife111 (8.3)129 (9.6)39 (2.95)34 (2.5)199 (14.8)46 (3.4)159 (11.8)120 (8.9)
Others75 (5.6)65 (4.8)32 (2.4)25 (1.9)119 (8.9)28 (2.1)97 (7.2)75 (5.6)
Working experience
0‐5204 (15.2)210 (15.6)73 (5.4)11.387.32843 (3.2)356 (26.5)88 (6.6)17.470.065266 (19.8)221 (16.5)17.784.007
5‐1090 (6.7)115 (8.6)47 (3.5)21 (1.6)175 (13.0)46 (4.2)119 (8.9)133 (9.9)
10‐1586 (6.4)125 (9.3)42 (3.1)30 (2.2)178 (13.3)45 (3.4)133 (9.9)120 (8.9)
15‐2053 (3.9)73 (5.4)25 (1.9)16 (1.2)116 (8.6)19 (1.4)87 (6.5)64 (4.8)
>2076 (5.7)92 (6.8)32 (2.4)24 (1.7)155 (11.5)21 (1.6)118 (8.7)82 (6.1)
Employment status
Conscription79 (5.9)102 (7.6)36 (2.7)21.025.02115 (1.1)156 (11.6)46 (3.4)11.487.321108 (8.0)109 (8.1)11.361.045
Contractual84 (35.9)114 (48.7)36 (15.4)27 (2.0)167 (12.4)40 (3.0)128 (9.5)106 (7.9)
Corporate36 (2.7)50 (3.7)28 (2.1)11 (0.8)78 (5.8)25 (1.9)48 (3.6)66 (4.9)
Temporary‐to‐permanent45 (3.4)54 (4.0)18 (1.3)15 (1.1)86 (6.4)16 (1.2)63 (4.7)54 (4.0)
Permanent181 (13.5)239 (17.8)77 (5.7)47 (3.5)377 (28.1)73 (5.4)277 (20.6)220 (16.4)
Other84 (6.3)56 (4.2)24 (1.8)19 (1.4)116 (8.6)29 (2.2)99 (7.4)65 (4.8)
Working in isolated wards
Yes211 (15.7)283 (21.1)90 (6.7)2.967.22761 (4.5)416 (31.0)107 (8.0)1.632.442310 (23.1)274 (20.4)0.235.628
No298 (22.2)332 (24.7)129 (9.6)73 (5.4)564 (42.0)122 (9.1)413 (30.8)346 (25.8)
Working units
Hospitals223 (16.6)293 (21.8)293 (21.8)10.46.40148 (3.6)460 (34.3)111 (8.3)16.010.099322 (24.0)297 (22.1)6.525.258
Outpatient clinics69 (5.1)103 (7.7)103 (7.7)16 (1.2)157 (11.7)30 (2.2)102 (7.6)101 (7.5)
Laboratories14 (1.0)15 (1.1)5 (0.4)6 (0.4)24 (1.8)4 (0.3)21 (1.6)13 (1)
Imaging centers8 (0.6)7 (0.5)1 (0.1)1 (0.1)13 (1)2 (0.1)9 (0.7)7 (0.5)
Other195 (14.5)197 (14.6)79 (5.9)63 (4.7)326 (24.3)82 (6.1)269 (20.1)202 (15)
Working hours with COVID‐19 patients
096 (7.1)88 (6.6)26 (1.9)17.012.07433 (2.5)151 (11.2)26 (1.9)36.057<.001137 (1.2)73 (5.4)23.618<.001
1‐282 (6.1)102 (7.6)30 (2.2)23 (1.7)162 (12.1)29 (2.2)120 (8.9)94 (7.0)
2‐443 (3.2)64 (4.8)20 (1.5)7 (0.5)104 (7.7)16 (1.2)70 (5.2)57 (4.2)
4‐678 (5.8)78 (5.8)26 (1.9)22 (1.6)133 (9.9)27 (2.0)107 (8.0)75 (5.6)
6‐8143 (10.6)206 (15.3)87 (6.5)27 (2.0)320 (23.8)89 (6.6)205 (15.3)231 (17.2)
>867 (5.0)77 (5.7)30 (2.2)22 (1.6)110 (8.2)42 (3.1)84 (6.3)90 (6.7)
History of physical illnesses
Yes105 (7.8)146 (109)77 (5.7)17.803<.00129 (2.2)239 (17.8)60 (4.5)0.954.621159 (11.8)169 (12.6)5.015.025
No404 (30.1)469 (34.9)142 (10.6)105 (7.8)741 (55.2)169 (12.6)564 (42.0)451 (33.6)
History of psychiatric disorders
Yes42 (3.1)61 (4.5)29 (2.2)4.313.116115 (1.1)83 (6.2)34 (2.5)8.832.01264 (4.8)68 (5.1)1.686.194
No467 (34.8)554 (41.3)190 (14.1)119 (8.9)897 (66.8)195 (14.5)659 (49.1)552 (41.1)
Prevalence of anxiety based on CDAS and DASS CDAS in participants during COVID‐19 outbreak in Mazandaran Providence population stratified by sociodemographic variables (N = 1343)

Prevalence of depression based on DASS

The DASS results are shown in Tables 2 and 4. In this regard, 35.1% of the HCPs had experienced depression during this pandemic. In addition, depression was significantly correlated with age, marital status, having children, working experience, employment status, and history of mental problems (P < .05).
TABLE 4

Prevalence of depression, anxiety, and stress based on DASS

VariablesSeverity of depressionSeverity of anxietySeverity of stress
Normal (%)Mild (%)Moderate (%)Severe (%)Very severe (%) χ 2 P‐valueNormal (%)Mild (%)Moderate (%)Severe (%)Very severe (%) χ 2 P‐valueNormal (%)Mild (%)Moderate (%)Severe (%)Very severe (%) χ 2 P‐value
Gender
Male235 (17.5)33 (2.5)41 (3.1)12 (0.9)15 (1.1)7.405.116259 (19.3)15 (1.1)35 (2.6)8 (0.6)19 (1.4)28.856<.001270 (20.1)22 (1.6)19 (1.4)17 (1.3)8 (0.6)13.871.008
Female637 (47.7)140 (10.4)118 (8.8)47 (3.5)65 (4.8)620 (46.2)81 (6.0)192 (14.3)49 (3.6)65 (4.8)707 (52.6)111 (8.3)85 (6.3)62 (4.6)42 (3.1)
Age groups
20‐30295 (22.0)62 (4.6)64 (4.8)40 (3.0)37 (2.8)41.82<.001306 (22.8)40 (3.0)84 (6.3)33 (2.5)35 (2.6)28.878.025326 (24.3)62 (4.6)47 (3.5)37 (2.8)26 (1.9)36.943.002
31‐40302 (22.5)59 (4.4)57 (2.2)14 (1.0)27 (2.0)294 (21.9)36 (2.7)82 (6.1)14 (1.0)33 (2.5)335 (24.9)40 (3.0)40 (3.0)29 (2.2)15 (1.1)
41‐50206 (15.3)43 (3.2)28 (2.1)5 (0.4)14 (1.0)208 (15.5)14 (1.0)49 (3.6)10 (0.7)15 (1.1)237 (17.6)23 (1.7)16 (1.2)12 (0.9)8 (0.6)
51‐6064 (4.8)9 (0.7)8 (0.6)0 (0.0)2 (0.1)66 (4.9)6 (0.4)10 (0.7)0 (0.0)1 (0.1)73 (5.4)7 (0.5)1 (0.1)1 (0.1)1 (0.1)
>605 (0.4)0 (0.0)2 (0.1)0 (0.0)0 (0.0)5 (0.4)0 (0.0)2 (0.1)0 (0.0)0 (0.0)6 (0.4)1 (0.1)0 (0.0)0 (0.0)0 (0.0)
Marital status
Single203 (15.1)42 (3.1)53 (3.9)24 (1.8)25 (1.9)18.408.018224 (16.7)29 (2.2)52 (3.9)17 (1.3)25 (1.9)4.472.812237 (17.6)40 (3.0)32 (2.4)23 (1.7)15 (1.1)6.965.54
Married648 (48.3)128 (9.5)100 (7.4)34 (2.5)54 (4.0)632 (47.1)66 (4.9)169 (12.6)39 (2.9)58 (4.3)715 (53.2)89 (6.6)70 (5.2)56 (4.2)34 (2.5)
Divorced or widowed21 (1.6)3 (0.2)6 (0.4)1 (0.1)1 (0.1)23 (1.7)1 (0.1)6 (0.4)1 (0.1)1 (0.1)25 (1.9)4 (0.3)2 (0.1)0 (0.0)1 (0.1)
Having children
Yes499 (37.2)102 (7.6)85 (6.3)18 (1.3)43 (3.2)17.178.002491 (36.6)52 (3.9)133 (9.9)24 (1.8)47 (3.5)5.135.274567 (42.2)67 (5.5)51 (3.8)38 (2.8)24 (1.8)8.6.072
No373 (27.8)71 (5.3)74 (5.5)41 (3.1)37 (2.8)388 (28.9)44 (3.3)94 (7.0)33 (2.5)37 (2.8)410 (30.5)66 (4.9)53 (3.9)41 (3.1)26 (1.9)
Level of education
Undergraduate87 (6.5)9 (0.7)22 (1.6)4 (0.3)11 (0.8)21.009.0592 (6.9)6 (0.4)17 (1.3)7 (0.5)11 (0.8)22.534.032103 (7.7)8 (0.6)8 (0.6)10 (0.7)4 (0.3)9.896.625
Bachelor's degree491 (36.6)108 (8.0)85 (6.3)41 (3.1)43 (3.2)475 (35.4)65 (4.8)143 (10.6)34 (2.5)51 (3.8)548 (40.8)84 (6.3)63 (4.7)44 (3.3)29 (2.2)
Master's and PhD degree126 (9.4)20 (1.5)12 (0.9)4 (0.3)10 (0.7)120 (8.9)12 (0.9)28 (2.1)1 (0.1)11 (0.8)134 (10.0)14 (1.0)9 (0.7)7 (0.5)6 (0.6)
General and special professional doctorate168 (12.5)36 (2.7)40 (3.0)10 (0.7)16 (1.2)192 (14.3)13 (1.0)39 (2.9)15 (1.1)11 (0.8)192 (14.3)27 (2.0)24 (1.8)18 (1.3)9 (0.7)
Occupation
Clinician196 (14.6)41 (3.1)46 (3.4)17 (1.3)22 (1.6)15.529.214226 (16.8)14 (1.0)42 (3.1)20 (1.5)20 (1.5)23.669.023226 (16.8)32 (2.4)28 (2.1)21 (1.6)15 (1.1)19.494.077
Nurse365 (27.2)86 (6.4)57 (4.2)29 (2.2)33 (2.5)350 (26.1)52 (3.9)108 (8.0)22 (1.6)38 (2.8)403 (30.0)68 (5.1)42 (3.1)38 (2.8)19 (1.4)
Midwife193 (14.4)30 (2.2)32 (2.4)7 (0.5)17 (1.3)183 (13.6)22 (1.6)52 (3.9)10 (0.7)12 (0.9)207 (15.4)26 (1.9)25 (1.9)14 (1.0)7 (0.5)
Others118 (8.8)16 (1.2)24 (1.8)6 (0.4)8 (0.6)120 (8.9)8 (0.6)25 (1.9)5 (0.4)14 (1.0)141 (10.5)7 (0.5)9 (0.7)6 (0.4)9 (0.7)
Working experience
0‐5300 (22.3)52 (3.9)68 (5.1)32 (2.4)35 (2.6)33.162.032310 (23.1)44 (3.3)70 (5.2)31 (2.3)32 (2.4)28.198.105335 (24.9)52 (3.9)44 (3.3)35 (2.6)21 (1.6)36.224.014
5‐10162 (12.1)42 (3.1)23 (1.7)10 (0.7)15 (1.1)166 (12.4)13 (1.0)50 (3.7)8 (0.6)15 (1.1)177 (13.2)29 (2.2)20 (1.5)13 (1.0)13 (1.0)
10‐15168 (12.5)30 (2.2)31 (2.3)11 (0.8)13 (1.0)159 (11.8)18 (1.3)49 (3.6)8 (0.6)19 (1.4)180 (13.4)28 (2.1)21 (1.6)16 (1.2)8 (0.6)
15‐20100 (7.4)25 (1.9)16 (1.2)5 (0.4)5 (0.4)100 (7.4)11 (0.8)27 (2.0)5 (0.4)8 (0.6)116 (8.6)10 (0.7)14 (1.0)11 (0.8)0 (0.0)
>20142 (10.5)24 (1.8)21 (1.6)6 (0.5)12 (0.9)144 (10.7)10 (0.7)31 (2.3)5 (0.3)10 (0.7)169 (12.6)14 (1.0)5 (0.4)4 (0.3)8 (0.5)
Employment status
Conscription128 (9.5)23 (1.7)34 (2.5)16 (1.2)16 (1.2)32.409.039133 (9.9)18 (1.3)32 (2.4)16 (1.2)18 (1.3)23.721.255145 (10.8)23 (1.7)22 (1.6)15 (1.1)12 (0.9)28.784.092
Contractual155 (11.5)37 (2.8)22 (1.6)9 (0.7)11 (0.8)163 (12.1)14 (1.0)35 (2.6)11 (0.8)11 (0.8)172 (12.8)25 (1.9)18 (1.3)12 (0.9)7 (0.5)
Corporate73 (5.4)15 (1.1)15 (1.1)6 (0.4)5 (0.4)65 (4.8)12 (0.9)27 (2.0)4 (0.3)6 (0.4)79 (5.9)12 (0.9)14 (1.0)5 (0.4)4 (0.3)
Temporary‐to‐permanent77 (5.7)21 (1.6)9 (0.7)5 (0.4)5 (0.4)78 (5.8)8 (0.6)22 (1.6)4 (0.3)5 (0.4)89 (6.6)11 (0.8)6 (0.4)10 (0.7)1 (0.1)
Permanent341 (25.4)62 (4.6)51 (3.8)15 (1.1)28 (2.1)331 (24.6)34 (2.5)88 (6.6)14 (1.1)30 (2.2)385 (28.7)46 (3.4)26 (1.9)23 (1.7)17 (1.3)
Other98 (7.3)15 (1.1)28 (2.1)8 (0.6)15 (1.1)109 (8.1)10 (0.7)23 (1.7)8 (0.6)14 (1.0)107 (8.0)16 (1.2)18 (1.3)14 (1.0)9 (0.7)
Working in isolated wards
Yes372 (27.7)82 (6.1)71 (5.3)25 (1.9)34 (2.5)1.469.832374 (27.8)42 (3.1)105 (7.8)29 (2.2)34 (2.5)2.602.626410 (30.5)70 (5.2)46 (3.4)41 (3.1)17 (1.3)9.575.048
No500 (37.2)91 (6.8)88 (6.6)34 (2.5)46 (3.4)505 (37.6)54 (4.0)122 (9.1)28 (2.1)50 (3.7)567 (42.2)63 (4.7)58 (4.3)38 (2.8)33 (2.5)
Working units
Hospitals397 (29.6)85 (6.3)77 (5.7)25 (1.9)35 (2.6)13.517.854392 (29.2)52 (3.9)109 (8.1)27 (2.0)39 (2.9)15.393.753444 (33.1)71 (5.3)47 (3.5)37 (2.8)20 (1.5)18.243.571
Outpatient clinics130 (9.7)27 (2.0)23 (1.7)12 (0.9)11 (0.8)140 (10.4)14 (1.0)26 (1.9)9 (0.7)14 (1.0)149 (11.1)16 (1.2)15 (1.1)14 (1.0)9 (0.7)
Laboratories24 (1.8)3 (0.2)3 (0.2)0 (0.0)4 (0.3)25 (1.9)1 (0.1)4 (0.3)0 (0.0)4 (0.3)28 (2.1)1 (0.1)1 (0.1)0 (0.0)4 (0.3)
Imaging centers11 (0.8)2 (0.1)2 (0.1)1 (0.1)0 (0.0)12 (0.9)0 (0.0)3 (0.2)0 (0.0)1 (0.1)14 (1.0)1 (0.1)0 (0.0)1 (0.1)0 (0.0)
Other310 (23.1)56 (4.2)54 (4.1)21 (1.6)30 (2.2)310 (23.1)29 (2.1)85 (6.4)21 (1.5)26 (2.0)342 (25.5)44 (3.3)41 (3.1)27 (2.0)17 (1.3)
Working hours with COVID‐19 patients
0142 (10.6)20 (1.5)28 (2.1)9 (0.7)11 (0.8)17.061.649144 (10.7)10 (0.7)37 (2.8)8 (0.6)11 (0.8)21.146.389158 (11.8)16 (1.2)19 (1.4)10 (0.7)7 (0.5)9.891.97
1‐2137 (10.2)30 (2.2)16 (1.2)12 (0.9)19 (1.4)137 (10.2)13 (1.0)41 (3.1)8 (0.6)15 (1.1)151 (11.2)21 (1.6)18 (1.3)16 (1.2)8 (0.6)
2‐481 (6.0)17 (1.3)15 (1.1)7 (0.5)7 (0.5)92 (6.9)7 (0.5)17 (1.3)3 (0.2)8 (0.6)88 (6.6)17 (1.3)10 (0.7)9 (0.7)3 (0.2)
4‐6121 (9.0)22 (1.6)23 (1.7)4 (0.3)12 (0.9)130 (9.7)7 (0.5)28 (2.1)7 (0.5)10 (0.7)137 (10.2)17 (1.3)11 (0.8)11 (0.8)6 (0.4)
6‐8275 (20.5)65 (4.8)54 (4.0)21 (1.6)21 (1.6)266 (19.8)43 (3.2)78 (5.8)20 (1.5)29 (2.9)321 (23.9)45 (3.4)29 (2.9)23 (1.7)18 (1.3)
>8116 (8.6)19 (1.4)23 (1.7)6 (0.4)10 (0.7)110 (8.2)16 (1.2)26 (1.9)11 (0.8)11 (0.8)122 (9.1)17 (1.3)17 (1.3)10 (0.7)8 (0.6)
History of physical illness
Yes208 (15.5)42 (3.1)48 (3.6)7 (0.5)23 (1.7)8.872.064190 (14.1)24 (1.8)65 (4.8)19 (1.4)30 (2.2)14.206.007231 (17.2)37 (2.8)22 (1.6)19 (1.4)19 (1.4)6.754.149
No664 (49.4)131 (9.8)111 (8.3)52 (3.9)57 (4.2)689 (51.3)72 (5.4)162 (12.1)38 (2.8)54 (4.0)746 (55.5)96 (7.1)82 (6.1)60 (4.5)31 (2.3)
History of psychiatric disorders
Yes53 (3.9)18 (1.3)29 (2.2)9 (0.7)23 (1.7)60.872<.00162 (4.6)5 (0.4)31 (2.3)14 (1.0)20 (1.5)46.189<.00168 (5.1)11 (0.8)20 (1.5)18 (1.3)15 (1.1)57.726<.001
No819 (61.0)155 (11.5)130 (9.7)50 (3.7)57 (4.2)817 (60.8)91 (6.8)196 (14.6)43 (3.2)65 (4.8)909 (67.7)122 (9.1)84 (6.3)61 (4.5)35 (2.6)
Prevalence of depression, anxiety, and stress based on DASS

Prevalence of anxiety based on DASS

The DASS results are illustrated in Tables 2 and 4. In this line, 34.5% of the HCPs showed anxiety that was significantly different in terms of gender, age, level of education, occupation, and history of physical and mental illnesses (P < .05).

Prevalence of stress based on DASS

The DASS results are provided in Tables 2 and 4. Accordingly, 27.8% of the HCPs lived through stress during this situation. The participants' stress was also significantly different with regard to gender, age, having children, working experience, working in isolated wards, and history of mental problems (P < .05).

Logistic regression for predictors of anxiety caused by COVID‐19

Table 5 shows the predictors of anxiety in relation to COVID‐19. The logistic regression model also revealed that anxiety caused by COVID‐19 was significantly correlated with age groups of 41‐50 years (OR = 0.493, 95% CI: 0.249‐0.828, P = .007), 51‐60 years (OR = 0.370, 95% CI: 0.167‐0.819, P = .014), working experience for 5‐10 years (OR = 1.545, 95% CI: 1.076‐2.219, P = .019), and 20‐25 years (OR = 2.176, 95% CI: 1.169‐4.048, P = .014), male participants (OR = 0.530, 95% CI: 0.401‐0.700, P < .001), working in hospitals (OR = 0.657, 95% CI: 0.454‐0.950, P = .026), and working 6‐8 hours (OR = 2.019, 95% CI: 1.357‐3.003, P = .001) and more than 5 hours (OR = 2.098, 95% CI: 1.304‐3.375, P = .002) with COVID‐19 patients.
TABLE 5

Logistic regression for predictors of anxiety

VariablesUnivariateMultivariate
OR95% CI P‐valueOR95% CI P‐value
Age
20‐30Ref.Ref.Ref.Ref.Ref.Ref.
31‐400.8600.667‐1.109.2450.6950.477‐1.013.058
41‐500.7340.549‐0.980.0360.4930.249‐0.828.007
51‐600.3970.239‐0.659<.0010.3700.167‐0.819.014
>600.3900.075‐2.032.2640.4550.071‐2.908.405
Marital status
SingleRef.Ref.Ref.Ref.Ref.Ref.
Married0.9950.778‐1.272.9661.0610.796‐1.415.686
Divorced or widowed0.7900.379‐1.651.5310.8330.383‐1.812.645
Working experience (y)
0‐5Ref.Ref.Ref.Ref.Ref.Ref.
5‐101.3450.992‐1.825.0571.5451.076‐2.219.019
10‐151.0860.801‐1.473.5961.4450.927‐2.254.104
15‐200.8850.612‐1.280.5181.3600.789‐2.344.268
20‐251.1640.780‐1.737.4562.1761.169‐4.048.014
25‐300.4860.290‐0.814.0061.1190.514‐2.435.777
Level of education
Under graduateRef.Ref.Ref.Ref.Ref.Ref.
Bachelor's degree1.2810.884‐1.854.1900.9040.584‐1.400.652
Master's and PhD degree0.9030.572‐1.426.6620.7540.457‐1.244.269
General and special professional doctorate0.7500.492‐1.143.1800.7820.412‐1.483.451
Occupation
ClinicianRef.Ref.Ref.Ref.Ref.Ref.
Nurse1.7161.300‐2.266<.0011.2530.725‐2.166.418
Midwife1.1740.847‐1.626.3350.9270.530‐1.620.789
Others1.2030.826‐1.751.3550.9680.583‐1.741.913
Gender
Male0.5170.400‐0.669<.0010.5300.401‐0.700<.001
FemaleRef.Ref.Ref.Ref.Ref.Ref.
Working in isolated wards
Yes1.0550.850‐1.310.6280.9420.717‐1.237.666
NoRef.Ref.Ref.Ref.Ref.Ref.
Working hours with COVID‐19 patients
0Ref.Ref.Ref.Ref.Ref.Ref.
1‐21.4700.994‐2.175.0541.4940.980‐2.277.062
2‐41.5280.974‐2.398.0651.5440.950‐2.509.080
4‐61.3150.873‐1.198.1901.2540.798‐1.970.326
6‐82.1151.504‐2.973<.0012.0191.357‐3.003.001
>82.0111.133‐3.033.0012.0981.304‐3.375.002
Working units
Hospital1.1390.874‐1.485.3350.6570.454‐0.950.026
Outpatient clinics1.2230.864‐1.723.2570.9780.653‐1.466.916
Laboratory0.7650.371‐1.577.4680.6520.283‐1.504.316
Imaging centers0.9610.350‐2.639.9380.6780.231‐1.986.478
OthersRef.Ref.Ref.Ref.Ref.Ref.
Logistic regression for predictors of anxiety

DISCUSSION

The main purpose of this study was to assess the levels of depression, anxiety, and stress among HCPs in Mazandaran Province, northern Iran. Most of the HCPs reported moderate physical (45.8%) and psychological (73%) symptoms of anxiety according to the CDAS. However, 34.5% of the HCPs showed anxiety based on the DASS. It meant that they had moderate anxiety caused by COVID‐19. In a study that conducted on Asian countries revealed Iran was the third country to experience the psychological effects of the COVID‐19 pandemic. Another Iranian study revealed COVID‐19 had been developed psychological distress among HCPs. In this line, Noorbala et al had demonstrated that about 29.5% of the Iranian population had anxiety. Roy et al had further reported that approximately 72% of the Indian citizens were being worried about themselves and their close family during the COVID‐19 pandemic. As well, Moghanibashi‐Mansourieh had reported that 50.9% of the Iranian population had shown mild‐to‐very‐severe anxiety in times of the COVID‐19 outbreak. A study in Tehran Province, Iran, had additionally revealed that 39.6% of 1038 HCPs had moderate‐to‐severe anxiety during the COVID‐19 pandemic. In the present study, the level of anxiety was also significantly different in terms of age, gender, level of education, occupation, working experience, working hours with COVID‐19 patients, and history of physical illnesses based on the CDAS. Accordingly, 16.5% of the HCPs with working experience less than 5 years showed anxiety symptoms. In addition, being female and younger was associated with higher prevalence rate of anxiety, supporting the results of the survey by Elbay et al. Nevertheless, Elbay et al believed that frontline workers had more anxiety, but in the present study, working in the isolated wards led to no significant discrepancy. In some hospitals in Iran, once the patients were presented with clinical symptoms of COVID‐19, they would not be transferred to an isolated ward for COVID‐19 until the tests were positive and the disease was verified. This could cause anxiety among HCPs even in nonisolated wards. On the other hand, HCPs with high risk for underlying conditions and anxiety disorder may not be employed in high‐risk wards. Moreover, 35.1% of the participants showed mild‐to‐very‐severe depression that was significantly different in terms of age, marital status, having children, working experience, employment status, and history of psychiatric disorders. These results were consistent with the study conducted in New York, where the researchers reported that 48% of the HCPs had depressive disorder symptoms. Noorbala et al had further found that 10.39% of the Iranian population had been diagnosed with suspected severe depression. Although the present study was conducted in the second months of the COVID‐19 outbreak, depression may be higher than now. Liu et al had also reported that HCPs and other individuals, spending time in quarantine because of an infectious disease outbreak, might be at high risk for depression, even over 3 years later. With respect to the upward trend in the number of COVID‐19 patients, the HCPs have to face massive workload. One survey had similarly demonstrated that depressive disorder symptoms in medical residents could be significantly associated with the number of working hours per week. However, in the present study, working hours with patients were not significantly correlated with depression. A previous study had further described that the years of being employed in hospitals had been significantly and inversely correlated with symptoms of depression. Approximating to the findings of the present study, HCPs with less than 15 years of working experience had shown more depressive disorder symptoms than those with more than 15 years of experience (26.9% vs 8.7%, respectively). Married HCPs could also feel more depressed compared with other participants. Although marital satisfaction has been conceived as a protective factor in the development of depression, marital status may be an additional psychological pressure and a source of anxiety during this pandemic and even lead to depression in HCPs. Likewise, the statistical tests revealed no significant relationship between men and women. But, in other studies, female HCPs had more symptoms of depression than males. , In the present study, the HCPs who were 40 years old and younger showed more depressive disorder symptoms. In line with the study by Huang and Zhao, HCPs who were under 35 years of age had been more likely to develop symptoms of depression than other age groups. In addition, depressive disorder had shown higher prevalence rates among people younger than 45 years old. The average age of the onset of recurrent unipolar major depressive episode could also fall between the ages of 30 and 35 years. Furthermore, stress was significantly diverse in terms of gender, age, working experience, working in isolated wards, and history of mental illnesses. In this vein, Zhang and Ma had reported that COVID‐19 had a mild stressful impact on different populations. Jahrami et al had also reported that 85% of the HCPs had moderate‐to‐severe stress; however, in the present study, 27.8% of the individuals had stress symptoms. In the Wang et al study, the prevalence of stress was 8.1%. This discrepancy might be due to different healthcare systems and the time of study implementation. Therefore, after a while, the HCPs had learned how to behave during this pandemic. As well, Alipoor et al had observed that the longer the working experience, the lower the stress, which was consistent with the present study. In addition, stress symptoms in the present study were not significantly correlated with occupation. But, in the study by Jahrami, nurses had more stress than others. Shechter et al also believed that nurses had higher rates of positive acute stress due to their different responsibilities. They were additionally spending more time delivering direct patient care. As stated by Jahrami et al (2020), long working hours per week, anxiety, and being an only child in family were among the important factors developing stressful conditions among nurses. Accordingly, stress was positively correlated with anxiety, so that the higher the stress load, the higher the anxiety. In spite of a significant difference in terms of anxiety among various occupations, nurses (22.3%), clinicians (9.4%), and midwives (8.9%) included in the present study had no significant differences with regard to stress symptoms. The finding of the present study showed the side effects of COVID‐19 pandemic on mental health HCPs. It is recommended that healthcare managers provide a better work environment, internet psychotherapy, cognitive behavior therapy (CBT), especially internet CBT to protect mental health and prevent spread of COVID‐19 disease. , The study was limited to a group of individuals having access to the Internet and social media, so it could not be generalized to general population. Also, the structured clinical interview and functional neuroimaging is necessary to definitive psychological diagnosis , but this study used self‐reported questionnaires to assess psychiatric symptoms.

CONCLUSION

Among the participants completing the questionnaire, most of the HCPs had moderate physical and psychological symptoms induced by COVID‐19. In addition, about one‐third of the cases had mild‐to‐very‐severe depression and stress. Accordingly, healthcare managers must focus more attention on psychological aspects among HCPs during this pandemic and plan to teach them about coping strategies.

CONFLICT OF INTEREST

The authors declared no competing interests in this study.

AUTHOR CONTRIBUTIONS

MK participated in collecting the data, interpreted findings, drafted the manuscript, and revised the manuscript. MM performed the statistical analysis. MA participated in study design, interpreted findings, and revised the manuscript. RG participated in collecting the data. MHR participated in revised the manuscript. FE participated in study design, collecting the data, re‐evaluated the data, interpreted the findings, and revised the manuscript. All authors read and approved the final manuscript.

FUNDING INFORMATION

This article is sponsored by Mazandaran University of Medical Sciences (No. 7333), Sari, Iran.

INFORMED CONSENT

This research project was approved by the Ethics Committee of Mazandaran University of Medical Sciences (IR.MAZUMS.REC.1399.7333), Sari, Iran. At the end of the questionnaire, the scores were also given as feedback to the participants. They were additionally assured that these scores were being used merely for screening purposes, but not treatment. Moreover, the HCPs who got high scores could contact the phone number 4030 (designed for free consultations by the Ministry of Health and Medical Education). In addition, the link of the educational files included videos and pamphlets prepared according to the HCPs' knowledge to teach them how to cope with depression, anxiety, and stress during this condition.

REGISTRY AND THE REGISTRATION NO. OF THE STUDY/TRIAL

Not applicable.
  41 in total

1.  Psychological Health of Surgeons in a Time of COVID-19: A Global Survey.

Authors:  Yi Quan Tan; Ziting Wang; Qai Ven Yap; Yiong Huak Chan; Roger C Ho; Agus Rizal Ardy Hariandy Hamid; Aitor Landaluce-Olavarria; Gianluca Pellino; Vineet Gauhar; Manish Chand; Marcelo Langer Wroclawski; B M Zeeshan Hameed; Samuel Ka-Kin Ling; Shomik Sengupta; Gaetano Gallo; Peter Ka-Fung Chiu; Yiloren Tanidir; M Pilar Villanova Tallada; Bernardo Nunez Garcia; Ramiro Colleoni; Zainal Adwin Zainal Abiddin; Riccardo Campi; Francesco Esperto; Diego Carrion; Dean Elterman; Amanda Shu Jun Chung; Anthony Chi Fai Ng; Marco Moschini; Juan Gomez Rivas; Julio Mayol; Jeremy Yuen-Chun Teoh; Edmund Chiong
Journal:  Ann Surg       Date:  2021-01-22       Impact factor: 12.969

2.  Depression after exposure to stressful events: lessons learned from the severe acute respiratory syndrome epidemic.

Authors:  Xinhua Liu; Meghana Kakade; Cordelia J Fuller; Bin Fan; Yunyun Fang; Junhui Kong; Zhiqiang Guan; Ping Wu
Journal:  Compr Psychiatry       Date:  2011-04-12       Impact factor: 3.735

3.  Depression, anxiety, stress levels of physicians and associated factors in Covid-19 pandemics.

Authors:  Rümeysa Yeni Elbay; Ayşe Kurtulmuş; Selim Arpacıoğlu; Emrah Karadere
Journal:  Psychiatry Res       Date:  2020-05-27       Impact factor: 3.222

4.  Anxiety and Depression in Health Workers and General Population During COVID-19 in IRAN: A Cross-Sectional Study.

Authors:  Leila Hassannia; Fatemeh Taghizadeh; Mahmood Moosazadeh; Mehran Zarghami; Hassan Taghizadeh; Azadeh Fathi Dooki; Mohammad Fathi; Reza Alizadeh-Navaei; Akbar Hedayatizadeh-Omran; Niloufar Dehghan
Journal:  Neuropsychopharmacol Rep       Date:  2020-12-25

5.  A Nationwide Survey of Psychological Distress among Italian People during the COVID-19 Pandemic: Immediate Psychological Responses and Associated Factors.

Authors:  Cristina Mazza; Eleonora Ricci; Silvia Biondi; Marco Colasanti; Stefano Ferracuti; Christian Napoli; Paolo Roma
Journal:  Int J Environ Res Public Health       Date:  2020-05-02       Impact factor: 3.390

6.  The examination of sleep quality for frontline healthcare workers during the outbreak of COVID-19.

Authors:  Haitham Jahrami; Ahmed S BaHammam; Haifa AlGahtani; Ahmed Ebrahim; MoezAlIslam Faris; Kawthar AlEid; Zahra Saif; Eman Haji; Ali Dhahi; Hussain Marzooq; Suad Hubail; Zainab Hasan
Journal:  Sleep Breath       Date:  2020-06-26       Impact factor: 2.655

7.  Is returning to work during the COVID-19 pandemic stressful? A study on immediate mental health status and psychoneuroimmunity prevention measures of Chinese workforce.

Authors:  Wanqiu Tan; Fengyi Hao; Roger S McIntyre; Li Jiang; Xiaojiang Jiang; Ling Zhang; Xinling Zhao; Yiran Zou; Yirong Hu; Xi Luo; Zhisong Zhang; Andre Lai; Roger Ho; Bach Tran; Cyrus Ho; Wilson Tam
Journal:  Brain Behav Immun       Date:  2020-04-23       Impact factor: 7.217

8.  Impact of the COVID-19 Pandemic on Mental Health and Quality of Life among Local Residents in Liaoning Province, China: A Cross-Sectional Study.

Authors:  Yingfei Zhang; Zheng Feei Ma
Journal:  Int J Environ Res Public Health       Date:  2020-03-31       Impact factor: 3.390

View more
  3 in total

1.  Multisectoral actions of mental health during the COVID-19 pandemic in Mazandaran province of Iran.

Authors:  Abdolkarim Ahmadi Livani; Farzad Gohardehi; Marzieh Azizi; Mahmoud Reza Hashemvarzi; Somayeh Taghavi; Sara Tonekaboni; Ramzanali Golchobi; Mehran Zarghami; Mohsen Aarabi; Forouzan Elyasi
Journal:  Neuropsychopharmacol Rep       Date:  2022-02-14

2.  Anxiety due to COVID-19 among healthcare providers during pandemic: A web-based cross-sectional survey in Iran.

Authors:  Mahsa Kamali; Mahmood Moosazadeh; Marzieh Azizi; Roya Ghasemian; Maryam Hasannezad Reskati; Forouzan Elyasi
Journal:  Neuropsychopharmacol Rep       Date:  2021-10-13

3.  Comparing mental health status and COVID-19 event impact between survivors and the general population during the second wave of the pandemic in Iran.

Authors:  Maryam Hasannezhad Reskati; Motahareh Kheradmand; Mahmood Moosazadeh; Touraj Assadi; Misagh Shafizad; Akbar Hedayatizadeh-Omran; Seyed Hamzeh Hosseini; Forouzan Elyasi
Journal:  Nurs Open       Date:  2022-08-26
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.